Neogenomics Share Price Today
(NASDAQ: NEO)

Name: Neogenomics Share Price Today (NASDAQ: NEO) - Neogenomics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Neogenomics share price is $14.3 & ₹1,238.95 as on 1 Feb 2025, 2.30 'hrs' IST

$14.3

▲

-0.5

(-3.38%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Neogenomics share price in Dollar and Rupees. Guide to invest in Neogenomics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Neogenomics, along with analyst recommendations, forecasts, and comprehensive financials.

Neogenomics share price movements

Today's Low: $14.29
Today's High: $14.88
$14.30
0.07%
Downside
Day's Volatility :3.97%
Upside
3.9%
52 Weeks Low: $12.13
52 Weeks High: $19.12
$14.30
15.21%
Downside
52 Weeks Volatility :36.57%
Upside
25.19%

Neogenomics (NEO) Returns

Period	Neogenomics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	1.13%	-0.6%	0.0%
6 Months	-11.78%	-2.8%	0.0%
1 Year	-2.59%	3.3%	0.0%
3 Years	-34.88%	11.6%	-13.7%

Neogenomics (NEO) Key Statistics

in dollars & INR

Previous Close	$14.8
Open	$14.8
Today's High	$14.88
Today's Low	$14.29
Market Capitalization	$1.8B
Today's Volume	$579.3K
52 Week High	$19.115
52 Week Low	$12.125
Revenue TTM	$644.1M
EBITDA	$-447.0K
Earnings Per Share (EPS)	$-0.61
Profit Margin	-12.07%
Quarterly Earnings Growth YOY	1.31%
Return On Equity TTM	-8.38%

How to invest in Neogenomics Stock (NEO) from India?

It is very easy for Indian residents to invest directly in Neogenomics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neogenomics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neogenomics or NEO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neogenomics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neogenomics shares which would translate to 0.061 fractional shares of Neogenomics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Neogenomics, in just a few clicks!

Returns in Neogenomics (NEO) for Indian investors in Rupees

The Neogenomics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Neogenomics investment value today

Current value as on today

₹1,01,971

Returns

₹1,971

(+1.97%)

Returns from Neogenomics Stock

₹2,589 (-2.59%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Neogenomics (NEO)

411.11%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Investment in Neogenomics Shares from India has grown by 411.11% over the past 30 days, indicating increased transactional activity.

127%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Neogenomics Stock from India on INDmoney has increased by 127% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Neogenomics

BlackRock Inc
15.51%
Vanguard Group Inc
10.94%
Brown Advisory Holdings Inc
5.37%
HHG PLC
5.14%
T. Rowe Price Investment Management,Inc.
5.10%
State Street Corp
3.86%

Analyst Recommendation on Neogenomics

Buy

76%Buy

23%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Neogenomics(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Neogenomics Stock (NEO)

What analysts predicted

Upside of 43.04%

Target:

$20.45

Current:

$14.30

Insights on Neogenomics Stock (Ticker Symbol: NEO)

Price Movement
In the last 1 month, NEO stock has moved down by -13.2%
Price Movement
In the last 3 months, NEO stock has moved down by -36.3%
Increasing Revenue
Revenue is up for the last 7 quarters, 137.22M → 167.82M (in $), with an average increase of 3.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -27.06M → -17.69M (in $), with an average increase of 25.2% per quarter
NEO vs A (1 yr)
In the last 1 year, Agilent Technologies Inc. has given 13.9% return, outperforming this stock by 17.3%
NEO vs A (3 yr)
In the last 3 years, Agilent Technologies Inc. has given 7.4% return, outperforming this stock by 45.5%
Price to Sales
ForNEO every $1 of sales, investors are willing to pay $2.8, whereas for Agilent Technologies Inc., the investors are paying $6.8 for every $1 of sales.

NEO Neogenomics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$276.7M	↑ 7.01%
Net Income	$2.6M	↓ 412.06%
Net Profit Margin	0.95%	↑ 1.28%

	FY19	Y/Y Change
Revenue	$408.8M	↑ 47.73%
Net Income	$8.0M	↑ 203.26%
Net Profit Margin	1.96%	↑ 1.01%

	FY20	Y/Y Change
Revenue	$444.4M	↑ 8.71%
Net Income	$4.2M	↓ 47.89%
Net Profit Margin	0.94%	↓ 1.02%

	FY21	Y/Y Change
Revenue	$484.3M	↑ 8.97%
Net Income	$-8.3M	↓ 300.07%
Net Profit Margin	-1.72%	↓ 2.66%

	FY22	Y/Y Change
Revenue	$509.7M	↑ 5.24%
Net Income	$-144.3M	↑ 1628.17%
Net Profit Margin	-28.3%	↓ 26.58%

	FY23	Y/Y Change
Revenue	$591.6M	↑ 16.07%
Net Income	$-88.0M	↓ 39.02%
Net Profit Margin	-14.87%	↑ 13.43%

	Q2 FY23	Q/Q Change
Revenue	$146.9M	↑ 7.07%
Net Income	$-24.3M	↓ 20.99%
Net Profit Margin	-16.56%	↑ 5.88%

	Q3 FY23	Q/Q Change
Revenue	$152.0M	↑ 3.43%
Net Income	$-18.5M	↓ 23.9%
Net Profit Margin	-12.19%	↑ 4.37%

	Q4 FY23	Q/Q Change
Revenue	$155.6M	↑ 2.37%
Net Income	$-14.3M	↓ 22.63%
Net Profit Margin	-9.21%	↑ 2.98%

	Q1 FY24	Q/Q Change
Revenue	$156.2M	↑ 0.44%
Net Income	$-27.1M	↑ 88.89%
Net Profit Margin	-17.32%	↓ 8.11%

	Q2 FY24	Q/Q Change
Revenue	$164.5M	↑ 5.29%
Net Income	$-18.6M	↓ 31.11%
Net Profit Margin	-11.33%	↑ 5.99%

	Q3 FY24	Q/Q Change
Revenue	$167.8M	↑ 2.02%
Net Income	$-17.7M	↓ 5.06%
Net Profit Margin	-10.55%	↑ 0.78%

	FY18	Y/Y Change
Profit	$127.3M	↑ 5.78%

	FY19	Y/Y Change
Profit	$196.8M	↑ 54.67%

	FY20	Y/Y Change
Profit	$185.9M	↓ 5.56%

	FY21	Y/Y Change
Profit	$187.1M	↑ 0.63%

	FY22	Y/Y Change
Profit	$187.9M	↑ 0.45%

	FY23	Y/Y Change
Profit	$244.6M	↑ 30.18%

	Q2 FY23	Q/Q Change
Profit	$59.9M	↑ 9.26%

	Q3 FY23	Q/Q Change
Profit	$62.3M	↑ 4.04%

	Q4 FY23	Q/Q Change
Profit	$67.6M	↑ 8.47%

	Q1 FY24	Q/Q Change
Profit	$62.0M	↓ 8.24%

	Q2 FY24	Q/Q Change
Profit	$69.0M	↑ 11.33%

	Q3 FY24	Q/Q Change
Profit	$74.9M	↑ 8.46%

	FY18	Y/Y Change
Operating Cash Flow	$44.8M	↑ 148.3%
Investing Cash Flow	$-139.7M	↑ 920.36%
Financing Cash Flow	$92.0M	↓ 2345.64%

	FY19	Y/Y Change
Operating Cash Flow	$23.4M	↓ 47.82%
Investing Cash Flow	$-19.6M	↓ 85.95%
Financing Cash Flow	$159.5M	↑ 73.41%

	FY20	Y/Y Change
Operating Cash Flow	$1.5M	↓ 93.75%
Investing Cash Flow	$-159.4M	↑ 712.23%
Financing Cash Flow	$235.6M	↑ 47.74%

	FY21	Y/Y Change
Operating Cash Flow	$-26.7M	↓ 1930.34%
Investing Cash Flow	$-632.4M	↑ 296.62%
Financing Cash Flow	$725.3M	↑ 207.85%

	FY22	Y/Y Change
Operating Cash Flow	$-66.0M	↑ 146.95%
Investing Cash Flow	$517.0K	↓ 100.08%
Financing Cash Flow	$11.8M	↓ 98.37%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.5M	↓ 87.8%
Investing Cash Flow	$14.9M	↓ 37.04%
Financing Cash Flow	$64.0K	↓ 95.36%

Neogenomics Technicals Summary

Sell

Neutral

Buy

Neogenomics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Neogenomics (NEO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Neogenomics, Inc.	-13.28%	-11.78%	-2.59%	-34.88%	-55.63%
Agilent Technologies Inc.	13.56%	12.49%	13.95%	5.05%	84.44%
Idexx Laboratories, Inc.	3.23%	-7.26%	-19.94%	-21.0%	53.04%
Thermo Fisher Scientific, Inc.	14.39%	-0.05%	8.32%	-1.06%	87.77%
Danaher Corp.	-3.08%	-17.3%	-9.58%	-24.35%	38.35%
Iqvia Holdings Inc.	3.2%	-13.82%	-4.46%	-20.86%	29.7%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Neogenomics, Inc.	NA	NA	3.02	0.1	-0.08	-0.03	NA	7.09
Agilent Technologies Inc.	34.13	34.13	2.55	5.57	0.25	0.08	0.0	20.53
Idexx Laboratories, Inc.	41.0	41.0	4.41	10.69	0.59	0.23	NA	19.72
Thermo Fisher Scientific, Inc.	36.77	36.77	2.21	23.34	0.13	0.05	0.0	128.08
Danaher Corp.	42.17	42.17	2.99	7.71	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.46	26.46	1.07	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Neogenomics, Inc.	Buy	$1.8B	-55.63%	NA	-12.07%
Agilent Technologies Inc.	Buy	$43.3B	84.44%	34.13	21.75%
Idexx Laboratories, Inc.	Buy	$34.7B	53.04%	41.0	22.53%
Thermo Fisher Scientific, Inc.	Buy	$232.1B	87.77%	36.77	14.48%
Danaher Corp.	Buy	$160.4B	38.35%	42.17	16.39%
Iqvia Holdings Inc.	Buy	$36.5B	29.7%	26.46	9.17%

Neogenomics Dividend announcements

Neogenomics Earnings
Neogenomics’s price-to-earnings ratio stands at None
Read More

About Neogenomics

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Organization	Neogenomics
Employees	2100
CEO	Mr. Christopher Michael Smith BSc
Industry	Health Services

Management People of Neogenomics

Name	Title
Mr. Christopher Michael Smith BSc	CEO & Director
Mr. Jeffrey S. Sherman M.B.A.	Chief Financial Officer
Ms. Melody Harris Esq., J.D.	President & COO of Informatics
Mr. Warren Stone	Chief Commercial Officer
Mr. Gregory D. Aunan	Chief Accounting Officer
Ms. Kendra Sweeney	Vice President of Investor Relations & Communications
Ms. Alicia Olivo	Executive VP of Business Development, General Counsel & Corporate Secretary
Mr. Hutan Hashemi J.D.	Chief Compliance Officer

Important FAQs about investing in NEO Stock from India :

What is Neogenomics share price today?

Neogenomics share price today stands at $14.30, Open: $14.80 ; Previous Close: $14.80 ; High: $14.88 ; Low: $14.29 ; 52 Week High: $19.12 ; 52 Week Low: $12.13.

The stock opens at $14.80, after a previous close of $14.80. The stock reached a daily high of $14.88 and a low of $14.29, with a 52-week high of $19.12 and a 52-week low of $12.13.

Can Indians buy Neogenomics shares?

Yes, Indians can invest in the Neogenomics (NEO) from India.

With INDmoney, you can buy Neogenomics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Neogenomics at zero transaction cost.

How can I buy Neogenomics shares from India?

It is very easy to buy Neogenomics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neogenomics (NEO) be purchased?

Yes, you can buy fractional shares of Neogenomics with INDmoney app.

What are the documents required to start investing in Neogenomics stocks?

To start investing in Neogenomics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.